Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Prolactin for Lactation Induction in Prolactin Deficient Mothers
NCT00181623Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2005
- Primary completion
- May 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of recombinant human prolactin in Prolactin deficiency, sponsored by Massachusetts General Hospital. Primary endpoint: Breast Milk Production at 28 days. Started Jan 2005; status: completed.
02
Drugs
recombinant human prolactin
03
Conditions
Prolactin deficiency
Beyond the preview
Go deeper on NCT00181623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181623.